Table 2 from First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer
收藏Figshare2025-07-15 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_2_from_First-in-Human_Phase_I_IIa_Study_of_the_First-in-Class_CDK2_4_6_Inhibitor_PF-06873600_Alone_or_with_Endocrine_Therapy_in_Patients_with_Breast_Cancer/29568356
下载链接
链接失效反馈官方服务：
资源简介：
Summary of TEAEs (>15%) by preferred term and maximum CTCAE grade in descending frequency order (treatment-related, all cycles)—safety analysis set parts 1 and 2 (N = 151).
创建时间：
2025-07-15
